Announcement • Aug 20
Ideagen Limited completed the acquisition of Envirosuite Limited (ASX:EVS). Ideagen Limited proposed to acquire Envirosuite Limited (ASX:EVS) for approximately AUD 130 million on February 25, 2025. A cash consideration valued at AUD 0.1 per share will be paid by Ideagen Limited. As per the announcement dated April 22, 2025 the bid price has been revised to AUD 0.09 per share.
The transaction is subject to approval of merger agreement by target board, approval of offer by court, FIRB, target shareholders, consummation of due diligence investigation and definitive agreement. The Board of directors of Envirosuite Limited unanimously recommend that the shareholders vote in favour of the scheme. As of June 20, 2025, Ideagen Limited received approval from Foreign Investment Review Board. The transaction will be funded by existing committed debt facilities and available cash. Sell side and buy termination fees for the transaction is AUD 1.32 million. Federal Court of Australia has approved the convening of a meeting of Envirosuite shareholders to consider and vote on the proposed acquisition of Envirosuite by Ideagen. As of August 1, 2025, the deal was approved by the shareholders of Envirosuite Limited. As of August 8, 2025, the second court meeting also approved the deal. The deal is expected to close on August 20, 2025. As of August 11, 2025, the scheme became legally effective.
Moelis Australia Securities Pty Ltd. acted as financial advisor for Envirosuite Limited. King & Wood Mallesons, Australia Branch acted as legal advisor to Envirosuite Limited. Morgan Stanley & Co. International plc acted as financial advisor to Ideagen Limited and MinterEllison as legal advisor. Grant Thornton Corporate Finance Pty Ltd, Investment Banking Arm acted as fairness opinion provider to Envirosuite Limited. Boardroom Pty Limited acted as registrar to Envirosuite Limited.
Ideagen Limited completed the acquisition of Envirosuite Limited (ASX:EVS) on August 20, 2025. Recent Insider Transactions Derivative • Aug 15
CEO, MD & Director exercised options to buy AU$358k worth of stock. On the 12th of August, Jason Cooper exercised options to buy 4m shares at a strike price of around AU$0.09, costing a total of AU$360k. This transaction amounted to 78% of their direct individual holding at the time of the trade. Since September 2024, Jason's direct individual holding has increased from 3.15m shares to 5.15m. Company insiders have collectively bought AU$576k more than they sold, via options and on-market transactions, in the last 12 months. New Risk • Aug 13
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 16% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Minor Risks Less than 1 year of cash runway based on current free cash flow (-AU$12m). Currently unprofitable and not forecast to become profitable over next 2 years (AU$5.3m net loss in 2 years). Shareholders have been diluted in the past year (16% increase in shares outstanding). Market cap is less than US$100m (AU$131.4m market cap, or US$86.0m).